Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications
- PMID: 2036219
- DOI: 10.1111/j.1699-0463.1991.tb05161.x
Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications
Abstract
An interobserver analysis of the reproducibility of malignancy grade and of histological type classified according to World Health Organization criteria was performed in 261 ovarian tumours, stages IIB to IV. All available slides per patient including metastatic tumours (16%) were reviewed independently by two pathologists. Overall observed agreement regarding type was 68%. The chance-corrected agreement expressed by the kappa coefficient was 0.55 (95% confidence interval 0.49-0.61). Overall observed agreement regarding grade was 41% compared with a kappa coefficient of 0.19 (95% confidence interval 0.12-0.26). Kappa coefficients, ranging from 0.18 to -1.00 for associations between type categories and from 0.20 to -0.32 for grade categories, indicated that any suggested pattern of association could be caused by chance occurrences. A more objective approach to histopathology is needed in ovarian carcinoma before its prognostic impact can be assessed.
Similar articles
-
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7. Hum Pathol. 2008. PMID: 18602670
-
Observer variation in histologic classification of malignant and borderline ovarian tumors.Hum Pathol. 1988 Sep;19(9):1030-5. doi: 10.1016/s0046-8177(88)80082-0. Hum Pathol. 1988. PMID: 3417288
-
Observer disagreement in histological classification of ovarian tumors in Japan.Gynecol Oncol. 1994 Jul;54(1):54-8. doi: 10.1006/gyno.1994.1165. Gynecol Oncol. 1994. PMID: 8020839
-
Ovarian carcinoma pathology and genetics: recent advances.Hum Pathol. 2009 Sep;40(9):1213-23. doi: 10.1016/j.humpath.2009.04.017. Epub 2009 Jun 24. Hum Pathol. 2009. PMID: 19552940 Review.
-
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27. Virchows Arch. 2017. PMID: 28025670 Free PMC article. Review.
Cited by
-
Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).Virchows Arch. 2009 Mar;454(3):249-56. doi: 10.1007/s00428-009-0725-y. Epub 2009 Jan 27. Virchows Arch. 2009. PMID: 19172293
-
Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America.Diagn Pathol. 2020 Jul 16;15(1):86. doi: 10.1186/s13000-020-01000-3. Diagn Pathol. 2020. PMID: 32677969 Free PMC article.
-
Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma.Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2545-2551. doi: 10.22034/APJCP.2018.19.9.2545. Asian Pac J Cancer Prev. 2018. PMID: 30256049 Free PMC article.
-
Histotype classification of ovarian carcinoma: A comparison of approaches.Gynecol Oncol. 2018 Oct;151(1):53-60. doi: 10.1016/j.ygyno.2018.08.016. Epub 2018 Aug 16. Gynecol Oncol. 2018. PMID: 30121132 Free PMC article.
-
[Ovarian carcinoma. Do the subtypes reflect different diseases?].Pathologe. 2008 Nov;29 Suppl 2:160-2. doi: 10.1007/s00292-008-1028-9. Pathologe. 2008. PMID: 18709371 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical